Login / Signup

Utility of pathologist panels for achieving consensus in NASH histologic scoring in clinical trials: Data from a phase 3 study.

Arun J SanyalStephen CaldwellQuentin Mark AnsteeVlad RatziuKris V KowdleyMary E RinellaStephen A HarrisonMurray B ResnickThomas CapozzaSangeeta SawhneyNirav ShelatZobair M Younossi
Published in: Hepatology communications (2023)
A panel of 3 trained pathologists independently scoring 4 NASH CRN histology parameters produced high consensus rates. Interpanel kappa values were comparable to NASH CRN metrics, supporting the accuracy and reproducibility of this method. The high concordance for fibrosis scoring was reassuring, as fibrosis is predictive of liver-specific outcomes and all-cause mortality.
Keyphrases
  • clinical trial
  • open label
  • clinical practice
  • electronic health record
  • type diabetes
  • randomized controlled trial
  • phase ii
  • toll like receptor
  • liver fibrosis
  • immune response
  • inflammatory response